Simon H. Stertzer, Director at BioCardia, Inc. (BCDA), bought 7,000 shares at $1.91 ($13K) on 2018-03-21, disclosed to the SEC on 2018-03-22.
Open-market purchase of $13k BCDA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.91 | 4,000 | $8K | 57.7% |
| 2 | $1.87 | 3,000 | $6K | 42.3% |
| Total | $1.89 avg | 7,000 | $13K | 100% |
| Filing → |
| BCDA | BUY | 2025-07-02 | $301K | — | Filing → |
| BCDA | BUY | 2025-04-25 | $401K | — | Filing → |
| BCDA | BUY | 2025-03-07 | $2K | — | Filing → |